Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 26.4% | 15.1% | (36.5%) | (3.3%) | (14.4%) | (8.1%) | (9.0%) | 3.9% | (44.6%) | (1.8%) | (1.8%) | (3.6%) | 5.3% | 1.5% | 21.2% | 41.6% | (0.6%) | 6.5% | 4.1% | 8.6% |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month Return on Equity (ROE) is 9.7%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Return on Equity (ROE) for Boston Scientific Corporation have been 5.9% over the past three years, and 11.1% over the past five years.
As of today, Boston Scientific Corporation's Return on Equity (ROE) is 9.7%, which is higher than industry median of (22.6%). It indicates that Boston Scientific Corporation's Return on Equity (ROE) is Good.